SlideShare une entreprise Scribd logo
1  sur  20
Pharmaceutical Excipients &
Formulation of a Dosage Form
Presented by Md. Faysal Id: 151-29-760
Cellulose acetate
 Non-proprietary name: BP : Cellulose acetate
USP : Cellulose acetate
 Chemical name: Cellulose acetate , Cellulose diacetate ,
Cellulose triacetate.
 Structure formula: C164H174O111
 Functional category:
 Coating agent
 Extended release agent
 Tablet and capsule diluent
 Application in pharmaceutical formulation:
 Used as a semipermeable coating on tablets.
 Used in transdermal drug delivery systems.
 Highly absorbent and resistant to moderate temperature.
 They don’t shrink or wrinkle.
 Stability and storage conditions:
 Stable if stored in a well-closed container in a cool, dry place .
 Incompatibilities:
 Incompatible with strongly acidic or alkaline substances.
Cellulose Acetate Phthalate
 Non-proprietary Name:
BP: Cellacefate
USP: Cellacefate
 Chemical Name:
Cellulose, acetate, 1,2-benzenedicarboxylate
 Structural Formula:
 Functional Category : Coating agent
 Applications in Pharmaceutical Formulation:
 Used as an enteric film coating material.
 Used as a matrix binder for tablets and capsules.
 Commonly applied to solid-dosage forms.
 Stability and Storage Conditions
 Stable if stored in a well-closed container in a cool, dry place.
 Incompatibilities
 Incompatible with ferrous surface, ferric chloride, sodium citrate.
Ceratonia
 Non-proprietary Names: None adopted.
 Chemical Name : Carob gum , Ceratonia silique.
 Structural Formula:
 Functional Category:
 Controlled-release agent
 Suspending agent
 Tablet binder
 Viscosity-increasing agent
 Applications in Pharmaceutical Formulation:
 Naturally occurring materials generally used as substitute for tragacanth.
 Used as a binder, thickening agent, and stabilizing agent in the cosmetics and
food industry.
 Stability and Storage Conditions
 Stored in a well-closed container in a cool, dry place.
 Ceratonia loses not more than 15% of its weight on drying.
 Incompatibilities
 The viscosity of xanthan gum solutions is increased in the presence of ceratonia.
Ceresin
 Non-proprietary Names: None adopted.
 Chemical Name: Ceresin
 Structural Formula:
 Functional Category:
 Coating Agent
 Stabilizing agent
 Stiffening agent
 Applications in Pharmaceutical Formulation:
 Used as a stiffening agent in creams and ointments.
 Emulsion stabilizer, viscosity control agent.
 Thickener in pharmaceutical protective, topical, and vaginal creams.
 Used in cosmetics and personal care products.
 Stability and Storage Conditions
 Stored in well-closed containers in a cool, dry, well-ventilated
place, away from extreme heat and strong oxidizing agents.
 Incompatibilities
 Incompatible with strong oxidizing agents.
Cetostearyl Alcohol
 Non-proprietary Names
BP: Cetostearyl Alcohol
USP-NF: Cetostearyl Alcohol
 Structural Formula: CH3(CH2)nOH
 Functional Category
 Emollient
 Emulsifying agent
 Viscosity-increasing agent
 Applications in Pharmaceutical Formulation:
 Used in cosmetics and topical pharmaceutical preparations.
 Used in the preparation of non aqueous creams sticks, and in non lathering
shaving creams.
 Stability and Storage Conditions
 Stable under normal storage conditions.
 Stored in a well-closed container in a cool, dry place.
 Incompatibilities
 Strong oxidizing agents and metal salts.
Cetrimide
 Non-proprietary Names:
BP: Cetrimide
PhEur: Cetrimide
 Structural Formula: C19H42BrN
 Functional Category
 Antimicrobial preservative
 Antiseptic
 Cationic surfactant
 Disinfectants
 Applications in Pharmaceutical Formulation:
 Quaternary ammonium compound that is used in cosmetics and pharmaceutical
formulations as an antimicrobial preservative.
 Used as a catholic surfactant.
 Stability and Storage Conditions
 Stable in the dry state, and also in aqueous solution at ambient temperatures.
 Bulk material should be stored in a well-closed container in a cool, dry place.
 Incompatibilities
 Incompatible with soaps, anionic surfactants, high concentrations of non-ionic
surfactants. Aqueous solutions react with metals.
Cetyl Alcohol
 Non-proprietary Names:
BP: Cetyl Alcohol
USP-NF: Cetyl Alcohol
 Chemical Name: Hexadecan-1-ol
 Structural Formula: C16H34O
 Functional Category:
 Coating agent
 Emulsifying agent
 Stiffening agent
 Applications in Pharmaceutical Formulation:
 Used in cosmetics and pharmaceutical formulations such as suppositories,
modified-release solid dosage forms, emulsions, lotions, creams.
 Used for its water absorption properties in water-in-oil emulsions and ointments.
 Stability and Storage Conditions
 Stable in the presence of acids, alkalis, light, and air.
 It does not become rancid.
 Stored in a well-closed container in a cool, dry place.
 Incompatibilities
 Incompatible with strong oxidizing agents
Cetylpyridinium Chloride
 Non-proprietary Names:
BP: Cetylpyridinium Chloride
USP: Cetylpyridinium Chloride
 Chemical Name:
1-Hexadecylpyridinium chloride
 Structural Formula: C21H38ClN
 Functional Category:
 Antimicrobial preservative
 Antiseptic
 Cationic surfactant
 Disinfectant
 Solubilizing agent
 Wetting agent
 Applications in Pharmaceutical Formulation:
 Used therapeutically as an antiseptic agent.
 Mouthwashes containing cetylpyridinium chloride have been shown to inhibit
plaque formation.
 Stability and Storage Conditions
 Stable under normal conditions. It should be stored in well-closed containers.
 Incompatibilities
 Incompatible with strong oxidizing agents and bases.
Chitosan
 Non-proprietary Names
BP: Chitosan Hydrochloride
PhEur: Chitosan Hydrochloride
 Chemical Name:
Poly-b-(1,4)-2-Amino-2-deoxy-D-glucose
 Structural Formula:
 Functional Category:
 Coating agent
 Disintegrates
 Film-forming agent
 Viscosity increasing agent
 Applications in Pharmaceutical Formulation:
 Used in cosmetics and is under investigation for use in a number of
pharmaceutical formulations.
 Stability and Storage Conditions
 Stable material at room temperature, although it is hygroscopic after drying.
Stored in a tightly closed container in a cool, dry place.
 Incompatibilities
 Incompatible with strong oxidizing agents
Final weight of tablet=300 mg
API (Ciprofloxacin)=150 mg
Excipients=150 mg
Ingredients
Names
Functions Amounts (mg) Amounts (%)
Ciprofloxacin API 150 mg
Ceratonia Tablet binder 12 mg 4%
Microcrystalline Disintegrates 30 mg 10%
Na Stearate Lubricants 3 mg 1%
Cellulose acetate
phthalate
Coating agents 4.5 mg 1.5%
Cellulose acetate Diluent 100.5 mg 33.5%
Formulation of Tablet

Contenu connexe

Tendances

Parenteral preparations,Injection Infusion, Powder for injection ,Concentrate...
Parenteral preparations,Injection Infusion, Powder for injection ,Concentrate...Parenteral preparations,Injection Infusion, Powder for injection ,Concentrate...
Parenteral preparations,Injection Infusion, Powder for injection ,Concentrate...FarsanaM
 
parenteral dosage form
parenteral dosage formparenteral dosage form
parenteral dosage formyogita rayate
 
Suppository - Types & Formulation
Suppository - Types & FormulationSuppository - Types & Formulation
Suppository - Types & FormulationZobayer Hossain
 
Sterile dosage forms d.pharmacy
Sterile dosage forms d.pharmacySterile dosage forms d.pharmacy
Sterile dosage forms d.pharmacyInshrahFatema1
 
Pharmaceuticals excipients
Pharmaceuticals excipientsPharmaceuticals excipients
Pharmaceuticals excipientsRAVINDER KUMAR
 
manufacturing of parenterals
manufacturing of parenteralsmanufacturing of parenterals
manufacturing of parenteralsSUPRAJA DEEP
 
Parenteral production and aseptic area
Parenteral production and aseptic areaParenteral production and aseptic area
Parenteral production and aseptic areaShaik Sana
 
Pharmaceutical excipients-MANIK
Pharmaceutical excipients-MANIKPharmaceutical excipients-MANIK
Pharmaceutical excipients-MANIKImran Nur Manik
 
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCT
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCTQUALITY CONTROL OF PARENTERALS,STERILE PRODUCT
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCTMuhammad Arsal
 
product formulation and development
product formulation and developmentproduct formulation and development
product formulation and developmentkalyaniArisettti
 
PHARMACEUTICAL EXCIPIENTS
PHARMACEUTICAL EXCIPIENTSPHARMACEUTICAL EXCIPIENTS
PHARMACEUTICAL EXCIPIENTSkamlesh wadher
 
Tablet types and Excipients
Tablet  types and ExcipientsTablet  types and Excipients
Tablet types and ExcipientsKomal Haleem
 

Tendances (20)

Large volume parenterals
Large volume parenteralsLarge volume parenterals
Large volume parenterals
 
Parenteral preparations,Injection Infusion, Powder for injection ,Concentrate...
Parenteral preparations,Injection Infusion, Powder for injection ,Concentrate...Parenteral preparations,Injection Infusion, Powder for injection ,Concentrate...
Parenteral preparations,Injection Infusion, Powder for injection ,Concentrate...
 
Sterile Products & admixtures
Sterile Products & admixturesSterile Products & admixtures
Sterile Products & admixtures
 
Types of parenteral formulations
Types of parenteral formulationsTypes of parenteral formulations
Types of parenteral formulations
 
parenteral dosage form
parenteral dosage formparenteral dosage form
parenteral dosage form
 
co-processed excipients ppt
co-processed excipients pptco-processed excipients ppt
co-processed excipients ppt
 
Injectable solutions
Injectable solutionsInjectable solutions
Injectable solutions
 
Suppository - Types & Formulation
Suppository - Types & FormulationSuppository - Types & Formulation
Suppository - Types & Formulation
 
Sterile dosage forms d.pharmacy
Sterile dosage forms d.pharmacySterile dosage forms d.pharmacy
Sterile dosage forms d.pharmacy
 
Pharmaceuticals excipients
Pharmaceuticals excipientsPharmaceuticals excipients
Pharmaceuticals excipients
 
DILUENTS AND DISINTEGRANTS
DILUENTS AND DISINTEGRANTSDILUENTS AND DISINTEGRANTS
DILUENTS AND DISINTEGRANTS
 
manufacturing of parenterals
manufacturing of parenteralsmanufacturing of parenterals
manufacturing of parenterals
 
Parenterals
ParenteralsParenterals
Parenterals
 
Parenteral production and aseptic area
Parenteral production and aseptic areaParenteral production and aseptic area
Parenteral production and aseptic area
 
Pharmaceutical excipients-MANIK
Pharmaceutical excipients-MANIKPharmaceutical excipients-MANIK
Pharmaceutical excipients-MANIK
 
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCT
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCTQUALITY CONTROL OF PARENTERALS,STERILE PRODUCT
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCT
 
Sterile dosage form
Sterile dosage formSterile dosage form
Sterile dosage form
 
product formulation and development
product formulation and developmentproduct formulation and development
product formulation and development
 
PHARMACEUTICAL EXCIPIENTS
PHARMACEUTICAL EXCIPIENTSPHARMACEUTICAL EXCIPIENTS
PHARMACEUTICAL EXCIPIENTS
 
Tablet types and Excipients
Tablet  types and ExcipientsTablet  types and Excipients
Tablet types and Excipients
 

Similaire à Pharmaceutical Excipients & Formulation of a Dosage Form

Pharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptxPharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptxMohammadShafique24
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients Nahid Hasan
 
Formulation of parenteral preparation wps office
Formulation of parenteral preparation wps officeFormulation of parenteral preparation wps office
Formulation of parenteral preparation wps officeSudipta Roy
 
Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)SumedhGhodke
 
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptxEXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptxDhruv Bhavsar
 
tablettypes-150309151055-conversion-gate01.pdf
tablettypes-150309151055-conversion-gate01.pdftablettypes-150309151055-conversion-gate01.pdf
tablettypes-150309151055-conversion-gate01.pdfSridharA50
 
LIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxLIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxSUJITHA MARY
 
Excipients.pptx asmita..
Excipients.pptx asmita..Excipients.pptx asmita..
Excipients.pptx asmita..asmitaprasad
 
formulation20additives20new-200403133429 (1).pdf
formulation20additives20new-200403133429 (1).pdfformulation20additives20new-200403133429 (1).pdf
formulation20additives20new-200403133429 (1).pdfshubhanginip123
 
Pharmaceutical Emulsion and Suppository
Pharmaceutical Emulsion and Suppository     Pharmaceutical Emulsion and Suppository
Pharmaceutical Emulsion and Suppository MEHEDI HASAN
 
Opthalmic products
Opthalmic productsOpthalmic products
Opthalmic productsArshad Khan
 
Semisolid dosage form..
Semisolid dosage form..Semisolid dosage form..
Semisolid dosage form..Rabab Ambreen
 
A view of pharmaceutical dosage forms
A view of pharmaceutical dosage formsA view of pharmaceutical dosage forms
A view of pharmaceutical dosage formsRavindra Kushwaha
 

Similaire à Pharmaceutical Excipients & Formulation of a Dosage Form (20)

Pharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptxPharmaceutical ingredient and excipient.pptx
Pharmaceutical ingredient and excipient.pptx
 
Excipients sb
Excipients sbExcipients sb
Excipients sb
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients
 
Pharmaceutical excipients
Pharmaceutical excipients Pharmaceutical excipients
Pharmaceutical excipients
 
Effervscent tab
Effervscent tabEffervscent tab
Effervscent tab
 
Formulation of parenteral preparation wps office
Formulation of parenteral preparation wps officeFormulation of parenteral preparation wps office
Formulation of parenteral preparation wps office
 
Pharmaceutical Additives
Pharmaceutical AdditivesPharmaceutical Additives
Pharmaceutical Additives
 
Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)Liquid dosage form Power Presentation ( Sem-I)
Liquid dosage form Power Presentation ( Sem-I)
 
Pharmaceutical Excipients
Pharmaceutical Excipients Pharmaceutical Excipients
Pharmaceutical Excipients
 
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptxEXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptx
 
tablettypes-150309151055-conversion-gate01.pdf
tablettypes-150309151055-conversion-gate01.pdftablettypes-150309151055-conversion-gate01.pdf
tablettypes-150309151055-conversion-gate01.pdf
 
LIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxLIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptx
 
Excipients.pptx asmita..
Excipients.pptx asmita..Excipients.pptx asmita..
Excipients.pptx asmita..
 
Parenteral Products.pptx
Parenteral Products.pptxParenteral Products.pptx
Parenteral Products.pptx
 
4 vol. 5, issue 9, sep 2014, re 1332, ijpsr, paper 4
4 vol. 5, issue 9, sep 2014, re 1332, ijpsr, paper 44 vol. 5, issue 9, sep 2014, re 1332, ijpsr, paper 4
4 vol. 5, issue 9, sep 2014, re 1332, ijpsr, paper 4
 
formulation20additives20new-200403133429 (1).pdf
formulation20additives20new-200403133429 (1).pdfformulation20additives20new-200403133429 (1).pdf
formulation20additives20new-200403133429 (1).pdf
 
Pharmaceutical Emulsion and Suppository
Pharmaceutical Emulsion and Suppository     Pharmaceutical Emulsion and Suppository
Pharmaceutical Emulsion and Suppository
 
Opthalmic products
Opthalmic productsOpthalmic products
Opthalmic products
 
Semisolid dosage form..
Semisolid dosage form..Semisolid dosage form..
Semisolid dosage form..
 
A view of pharmaceutical dosage forms
A view of pharmaceutical dosage formsA view of pharmaceutical dosage forms
A view of pharmaceutical dosage forms
 

Plus de faysalahmed35

Niosome and Liposome
Niosome and  LiposomeNiosome and  Liposome
Niosome and Liposomefaysalahmed35
 
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...faysalahmed35
 
Factor Viii Hemophilia
Factor Viii HemophiliaFactor Viii Hemophilia
Factor Viii Hemophiliafaysalahmed35
 
Model Pharmacy and its prospect in future
Model Pharmacy and its prospect in futureModel Pharmacy and its prospect in future
Model Pharmacy and its prospect in futurefaysalahmed35
 
Tablet Coating Machine
Tablet Coating MachineTablet Coating Machine
Tablet Coating Machinefaysalahmed35
 
Basic principle of IR spectroscoy
Basic principle of IR spectroscoy Basic principle of IR spectroscoy
Basic principle of IR spectroscoy faysalahmed35
 
Oral Contraceptive Pills
Oral Contraceptive Pills Oral Contraceptive Pills
Oral Contraceptive Pills faysalahmed35
 
Genetics differences affect drug metabolism
Genetics differences affect drug metabolismGenetics differences affect drug metabolism
Genetics differences affect drug metabolismfaysalahmed35
 
Sedative & Hypnotics ppt
Sedative & Hypnotics pptSedative & Hypnotics ppt
Sedative & Hypnotics pptfaysalahmed35
 
pharmaceutical suspension-ppt
pharmaceutical suspension-pptpharmaceutical suspension-ppt
pharmaceutical suspension-pptfaysalahmed35
 
High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)faysalahmed35
 
Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)faysalahmed35
 

Plus de faysalahmed35 (15)

Niosome and Liposome
Niosome and  LiposomeNiosome and  Liposome
Niosome and Liposome
 
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
 
Albendazole Tablet
Albendazole TabletAlbendazole Tablet
Albendazole Tablet
 
Factor Viii Hemophilia
Factor Viii HemophiliaFactor Viii Hemophilia
Factor Viii Hemophilia
 
Penicillin
PenicillinPenicillin
Penicillin
 
Model Pharmacy and its prospect in future
Model Pharmacy and its prospect in futureModel Pharmacy and its prospect in future
Model Pharmacy and its prospect in future
 
Tablet Coating Machine
Tablet Coating MachineTablet Coating Machine
Tablet Coating Machine
 
Hypertension
Hypertension Hypertension
Hypertension
 
Basic principle of IR spectroscoy
Basic principle of IR spectroscoy Basic principle of IR spectroscoy
Basic principle of IR spectroscoy
 
Oral Contraceptive Pills
Oral Contraceptive Pills Oral Contraceptive Pills
Oral Contraceptive Pills
 
Genetics differences affect drug metabolism
Genetics differences affect drug metabolismGenetics differences affect drug metabolism
Genetics differences affect drug metabolism
 
Sedative & Hypnotics ppt
Sedative & Hypnotics pptSedative & Hypnotics ppt
Sedative & Hypnotics ppt
 
pharmaceutical suspension-ppt
pharmaceutical suspension-pptpharmaceutical suspension-ppt
pharmaceutical suspension-ppt
 
High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)
 
Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)
 

Dernier

Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxheathfieldcps1
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxcallscotland1987
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.MaryamAhmad92
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSCeline George
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxAmanpreet Kaur
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Jisc
 

Dernier (20)

Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 

Pharmaceutical Excipients & Formulation of a Dosage Form

  • 1. Pharmaceutical Excipients & Formulation of a Dosage Form Presented by Md. Faysal Id: 151-29-760
  • 2. Cellulose acetate  Non-proprietary name: BP : Cellulose acetate USP : Cellulose acetate  Chemical name: Cellulose acetate , Cellulose diacetate , Cellulose triacetate.  Structure formula: C164H174O111  Functional category:  Coating agent  Extended release agent  Tablet and capsule diluent
  • 3.  Application in pharmaceutical formulation:  Used as a semipermeable coating on tablets.  Used in transdermal drug delivery systems.  Highly absorbent and resistant to moderate temperature.  They don’t shrink or wrinkle.  Stability and storage conditions:  Stable if stored in a well-closed container in a cool, dry place .  Incompatibilities:  Incompatible with strongly acidic or alkaline substances.
  • 4. Cellulose Acetate Phthalate  Non-proprietary Name: BP: Cellacefate USP: Cellacefate  Chemical Name: Cellulose, acetate, 1,2-benzenedicarboxylate  Structural Formula:  Functional Category : Coating agent
  • 5.  Applications in Pharmaceutical Formulation:  Used as an enteric film coating material.  Used as a matrix binder for tablets and capsules.  Commonly applied to solid-dosage forms.  Stability and Storage Conditions  Stable if stored in a well-closed container in a cool, dry place.  Incompatibilities  Incompatible with ferrous surface, ferric chloride, sodium citrate.
  • 6. Ceratonia  Non-proprietary Names: None adopted.  Chemical Name : Carob gum , Ceratonia silique.  Structural Formula:  Functional Category:  Controlled-release agent  Suspending agent  Tablet binder  Viscosity-increasing agent
  • 7.  Applications in Pharmaceutical Formulation:  Naturally occurring materials generally used as substitute for tragacanth.  Used as a binder, thickening agent, and stabilizing agent in the cosmetics and food industry.  Stability and Storage Conditions  Stored in a well-closed container in a cool, dry place.  Ceratonia loses not more than 15% of its weight on drying.  Incompatibilities  The viscosity of xanthan gum solutions is increased in the presence of ceratonia.
  • 8. Ceresin  Non-proprietary Names: None adopted.  Chemical Name: Ceresin  Structural Formula:  Functional Category:  Coating Agent  Stabilizing agent  Stiffening agent
  • 9.  Applications in Pharmaceutical Formulation:  Used as a stiffening agent in creams and ointments.  Emulsion stabilizer, viscosity control agent.  Thickener in pharmaceutical protective, topical, and vaginal creams.  Used in cosmetics and personal care products.  Stability and Storage Conditions  Stored in well-closed containers in a cool, dry, well-ventilated place, away from extreme heat and strong oxidizing agents.  Incompatibilities  Incompatible with strong oxidizing agents.
  • 10. Cetostearyl Alcohol  Non-proprietary Names BP: Cetostearyl Alcohol USP-NF: Cetostearyl Alcohol  Structural Formula: CH3(CH2)nOH  Functional Category  Emollient  Emulsifying agent  Viscosity-increasing agent
  • 11.  Applications in Pharmaceutical Formulation:  Used in cosmetics and topical pharmaceutical preparations.  Used in the preparation of non aqueous creams sticks, and in non lathering shaving creams.  Stability and Storage Conditions  Stable under normal storage conditions.  Stored in a well-closed container in a cool, dry place.  Incompatibilities  Strong oxidizing agents and metal salts.
  • 12. Cetrimide  Non-proprietary Names: BP: Cetrimide PhEur: Cetrimide  Structural Formula: C19H42BrN  Functional Category  Antimicrobial preservative  Antiseptic  Cationic surfactant  Disinfectants
  • 13.  Applications in Pharmaceutical Formulation:  Quaternary ammonium compound that is used in cosmetics and pharmaceutical formulations as an antimicrobial preservative.  Used as a catholic surfactant.  Stability and Storage Conditions  Stable in the dry state, and also in aqueous solution at ambient temperatures.  Bulk material should be stored in a well-closed container in a cool, dry place.  Incompatibilities  Incompatible with soaps, anionic surfactants, high concentrations of non-ionic surfactants. Aqueous solutions react with metals.
  • 14. Cetyl Alcohol  Non-proprietary Names: BP: Cetyl Alcohol USP-NF: Cetyl Alcohol  Chemical Name: Hexadecan-1-ol  Structural Formula: C16H34O  Functional Category:  Coating agent  Emulsifying agent  Stiffening agent
  • 15.  Applications in Pharmaceutical Formulation:  Used in cosmetics and pharmaceutical formulations such as suppositories, modified-release solid dosage forms, emulsions, lotions, creams.  Used for its water absorption properties in water-in-oil emulsions and ointments.  Stability and Storage Conditions  Stable in the presence of acids, alkalis, light, and air.  It does not become rancid.  Stored in a well-closed container in a cool, dry place.  Incompatibilities  Incompatible with strong oxidizing agents
  • 16. Cetylpyridinium Chloride  Non-proprietary Names: BP: Cetylpyridinium Chloride USP: Cetylpyridinium Chloride  Chemical Name: 1-Hexadecylpyridinium chloride  Structural Formula: C21H38ClN  Functional Category:  Antimicrobial preservative  Antiseptic  Cationic surfactant  Disinfectant  Solubilizing agent  Wetting agent
  • 17.  Applications in Pharmaceutical Formulation:  Used therapeutically as an antiseptic agent.  Mouthwashes containing cetylpyridinium chloride have been shown to inhibit plaque formation.  Stability and Storage Conditions  Stable under normal conditions. It should be stored in well-closed containers.  Incompatibilities  Incompatible with strong oxidizing agents and bases.
  • 18. Chitosan  Non-proprietary Names BP: Chitosan Hydrochloride PhEur: Chitosan Hydrochloride  Chemical Name: Poly-b-(1,4)-2-Amino-2-deoxy-D-glucose  Structural Formula:  Functional Category:  Coating agent  Disintegrates  Film-forming agent  Viscosity increasing agent
  • 19.  Applications in Pharmaceutical Formulation:  Used in cosmetics and is under investigation for use in a number of pharmaceutical formulations.  Stability and Storage Conditions  Stable material at room temperature, although it is hygroscopic after drying. Stored in a tightly closed container in a cool, dry place.  Incompatibilities  Incompatible with strong oxidizing agents
  • 20. Final weight of tablet=300 mg API (Ciprofloxacin)=150 mg Excipients=150 mg Ingredients Names Functions Amounts (mg) Amounts (%) Ciprofloxacin API 150 mg Ceratonia Tablet binder 12 mg 4% Microcrystalline Disintegrates 30 mg 10% Na Stearate Lubricants 3 mg 1% Cellulose acetate phthalate Coating agents 4.5 mg 1.5% Cellulose acetate Diluent 100.5 mg 33.5% Formulation of Tablet